Show simple item record

dc.date.accessioned2010-10-29T13:05:35Zen
dc.date.available2010-10-29T13:05:35Zen
dc.date.issued2001-02-01
dc.identifier.isbn978-1-84814-141-4
dc.identifier.urihttp://hdl.handle.net/10546/114044
dc.descriptionThis paper shows how new global patent rules, introduced by the World Trade Organisation, will raise the costs of vital medicines, with potentially disastrous implications for poor countries. In brief, these rules require all countries to provide patent protection for a minimum of 20 years for inventions in all fields of technology, including medicines. As the report points out, in the pharmaceutical sector the winners will be the large northern-based transnational companies which, as a result of the lengthened patent protection provided by WTO rules, will be able to sell their new medicines at higher prices. The losers are likely to be the millions of people who will be unable to afford vital new medicines, and hardpressed government health services.en_US
dc.format.extent37en_US
dc.format.mimetypePDFen_US
dc.language.isoEnglishen_US
dc.language.isoSpanishen_US
dc.publisherOxfam GBen_US
dc.relation.urlhttps://policy-practice.oxfam.org.uk/publications/patent-injustice-how-world-trade-rules-threaten-the-health-of-poor-people-114044
dc.subjectHealth
dc.titlePatent Injustice: How world trade rules threaten the health of poor peopleen_US
dc.typeBriefing paperen_US
oxfam.signoff.statusFor public use. Can be shared outside Oxfam.en_US
oxfam.subject.keywordAccess to medicinesen_US
oxfam.subject.keywordTRIPS and patentsen_US
oxfam.subject.keywordWorld Trade Organisationen_US
oxfam.subject.keywordWTOen_US
refterms.dateFOA2018-08-20T10:59:38Z


Files in this item

Thumbnail
Name:
bp-patent-injustice-010201-en.pdf
Size:
349.0Kb
Format:
PDF
Description:
English paper
Thumbnail
Name:
bp-patent-injustice-010201-sum ...
Size:
385.6Kb
Format:
PDF
Description:
Spanish summary

This item appears in the following Collection(s)

Show simple item record